Publications by: Tan N. Doan

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0 [feed] RSS 2.0
Number of items: 4.

Doan, Tan N., Fox, Greg J., Meehan, Michael T., Scott, Nick, Ragonnet, Romain, Viney, Kerri, Trauer, James M., and McBryde, Emma S. (2019) Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision analysis study. Journal of Antimicrobial Chemotherapy, 74 (1). pp. 218-227.

Doan, Tan N., Cao, Pengxing, Emeto, Theophilus I., Mccaw, James M., and McBryde, Emma S. (2018) Predicting the outcomes of new short-course regimens for multi-drug resistant tuberculosis using intrahost and pharmacokinetic-pharmacodynamic modelling. Antimicrobial Agents and Chemotherapy, 62 (12). e01487-18.

McBryde, Emma S., Meehan, Michael T., Doan, Tan N., Ragonnet, Romain, Marais, Ben J., Guernier, Vanina, and Trauer, James M. (2017) The risk of global epidemic replacement with drug-resistant Mycobacterium tuberculosis strains. International Journal of Infectious Diseases, 56. pp. 14-20.

Doan, Tan N., Eisen, Damon P., Rose, Morgan T., Slack, Andrew, Stearnes, Grace, and McBryde, Emma S. (2017) Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: a latent-class analysis. PLoS One, 12 (11). e0188631.

This list was generated on Tue Dec 10 04:47:03 2019 AEST.